inVentiv Health Provides Initial 2009 Financial Guidance

SOMERSET, N.J., Feb. 5, 2009 (GLOBE NEWSWIRE) -- inVentiv Health, Inc. (Nasdaq:VTIV), a leading provider of commercialization services to the global pharmaceutical and healthcare industries, today issued its initial 2009 financial targets. inVentiv provided total revenue targets for 2009 of $1.1 to $1.2 billion, which represents flat to mid-single digit growth over estimates for 2008. The company expects 2009 EBITDA to be relatively flat versus the prior year adjusted EBITDA with a targeted range of $135 to $155 million and earnings per share of $1.25 to $1.50.